MedTrace Logo

CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders

NCT01431235 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2017-01-16

No results posted yet for this study

Summary

The purpose of this study is to determine if cognitive behavioral therapy is effective in treating ADHD symptoms in patients with substance use disorders and comorbid ADHD.

Conditions

Interventions

BEHAVIORAL

cognitive behavioral therapy for treating ADHD symptoms

5 sessions of one hour CBT for treating ADHD symptoms by a trained health care worker

Sponsors & Collaborators

  • Fonds NutsOhra

    collaborator OTHER

  • Arkin

    lead INDUSTRY

Principal Investigators

  • Robert Schoevers, MD, PhD · University Medical Center Groningen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01431235 on ClinicalTrials.gov